| Name | Title | Contact Details |
|---|---|---|
Nallakkan Arvindan |
Chief Technology Officer | Profile |
Lucid Hearing hearing aids are affordable and ensure that you hear what you need to hear when you need to hear it. Come to one of our 500+ hearing centers nationwide and receive a free hearing test today.
Vilex is an innovative manufacturer of orthopaedic internal and external fixation devices, plates, and small joint implants.
Aphena Pharma Solutions New Jersey is a Whippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salix is committed to being the leading US specialty pharmaceutical company licensing, developing, and marketing innovative products to healthcare professionals to treat gastrointestinal disorders in patients.
UroGen Pharma is a biopharmaceutical company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel™ drug delivery technology platform, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery platform has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from pre-clinical to Phase III, we currently have multiple candidates in our pipeline, which are furthering the study of potential treatment advances in urology, uro-oncology, and immunology. Our collaborative drive: We are part of a broad ecosystem of partners who are seeking to improve patient care; these connections are vital to our commitment to offer new pathways and advance solutions. We currently have an exclusive worldwide license agreement with Allergan™ to evaluate the RTGel platform, an early-stage feasibility agreement with Janssen Pharmaceuticals™, and are continually evaluating new opportunities.